Skip to main content
    C

    cbdMD Inc (YCBD)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX

    $0.36
    -0.02 (-4.28%)

    Market Cap: $5.02M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    cbdMD Inc (YCBD) Financials: Revenue, Profit and Cash Flow

    Updated Aug 13, 2026. Financial statements from company filings, amounts in US dollars.

    cbdMD reported revenue of $19.19M for the fiscal year ended Sep 30, 2025, down 1.5% from the year before. That year, net income was -$2.04M with a net margin of -10.6%, operating cash flow was -$1.45M and free cash flow was -$1.64M. The quarter ended Jun 30, 2026 had revenue of $5.55M and net income of -$1.13M.

    Revenue and Margins

    The operating margin was -11.3% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from $5.26M, a compound annual rate of 15.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Sep 2025$19.19M-1.5%62.4%-11.3%-10.6%
    Sep 2024$19.48M-19.3%61.6%-17.0%-19.0%
    Sep 2023$24.16M-31.8%62.0%-93.1%-95.0%
    Sep 2022$35.40M-20.4%63.1%-221.1%-198.0%
    Sep 2021$44.48M+6.2%67.4%-44.1%-52.6%
    Sep 2020$41.88M+77.1%63.0%-42.0%30.1%
    Sep 2019$23.65M+1617.3%61.4%-62.6%-217.1%
    Sep 2018$1.38M-69.2%25.8%-130.5%4.6%
    Sep 2017$4.47M-15.0%69.7%-9.3%-31.0%
    Sep 2016$5.26MN/A7.9%-73.9%-74.0%
    Annual, fiscal years ended Sep 2016 to Sep 2025

    Income Statement

    In the fiscal year ended Sep 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Revenue$19.19M$19.48M$24.16M$35.40M$44.48M$41.88M$23.65M$1.38M$4.47M$5.26M
    Cost of revenue$7.22M$7.49M$9.18M$13.07M$14.50M$15.51M$9.14M$104.01K$1.36M$1.62M
    Gross profit$11.97M$12.00M$14.98M$22.34M$29.99M$26.37M$14.51M$355.08K$3.12M$413.13K
    Operating income-$2.16M-$3.32M-$22.49M-$78.27M-$19.62M-$17.58M-$14.80M-$1.80M-$414.29K-$3.89M
    Net income-$2.04M-$3.70M-$22.94M-$70.08M-$23.39M$12.60M-$51.36M$62.83K-$1.39M-$3.90M
    EBITDA-$279.29K-$1.85M-$20.26M-$65.71MN/A$14.10MN/A-$1.57M-$37.22K-$3.80M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$5.55M$5.64M$5.02M$4.72M$4.61M$4.75M$5.11M$4.56M$5.17M$4.38M$5.38M$5.71M
    Gross profit$3.04M$3.26M$3.00M$2.78M$2.83M$2.96M$3.40M$2.45M$3.40M$2.58M$3.56M$3.55M
    Operating income-$1.13M-$800.78K-$286.29K-$685.82K-$904.69K-$485.82K-$86.27K-$316.56K-$382.03K-$1.55M-$1.07M-$15.22M
    Net income-$1.13M-$797.98K-$283.13K-$679.97K-$895.27K-$480.76K$15.10K-$152.80K$459.74K-$3.01M-$996.50K-$15.87M
    Last 12 quarters

    Balance Sheet

    As of Sep 2025, cash and equivalents exceeded short-term debt of $0 by $2.26M.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Total assets$10.42M$10.58M$16.20M$40.79M$124.88M$110.84M$94.52M$15.02M$7.07M$1.62M
    Current assets$6.55M$6.39M$8.07M$16.01M$36.50M$23.71M$15.74M$11.79M$3.69M$956.32K
    Cash and equivalents$2.26M$2.45M$1.80M$6.72M$26.41M$14.82M$4.69M$4.28M$284.25K$34.26K
    Total liabilities$3.19M$8.62M$7.16M$9.37M$21.74M$31.66M$56.91M$998.46K$1.92M$1.92M
    Short-term debt$0$1.17M$2.49K$9.61K$59.47K$55.64K$0N/AN/A$797.55K
    Long-term debtN/AN/AN/A$125.49K$108.98K$602.10K$0N/A$360.00KN/A
    Shareholder equity$7.23M$1.96M$9.03M$31.42M$103.14M$79.18M$37.60M$12.61M$4.21M$363.43K
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$13.15M$12.25M$11.78M$10.42M$9.90M$10.94M$11.78M$10.58M$13.84M$14.55M$15.10M$16.20M
    Total liabilities$4.93M$2.97M$2.77M$3.19M$3.78M$10.27M$2.77M$8.62M$10.82M$11.46M$8.06M$7.16M
    Cash and equivalents$2.12M$2.64M$3.39M$2.26M$1.06M$1.77M$3.39M$2.45M$2.40M$2.11M$1.50M$1.80M
    Shareholder equity$8.21M$9.28M$9.01M$7.23M$6.11M$665.80K$9.01M$1.96M$3.03M$3.09M$7.04M$9.03M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Sep 2025.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Operating cash flow-$1.45M-$352.79K-$4.30M-$14.97M-$14.09M-$10.66M-$15.38M-$5.57M-$2.33M-$2.90M
    Capital expenditures$184.17K$190.01K$297.55K$688.68K$342.01K$1.32M$1.20M$23.56K$7.97K$127.26K
    Free cash flow-$1.64M-$542.81K-$4.60M-$15.66M-$14.44M-$11.98M-$16.58M-$5.60M-$2.34M-$3.02M
    Dividends paidN/A$0$3.67M$4.00M$2.55M$366.85K$0$366.85K$29.18KN/A
    Investing cash flow-$184.17K-$290.01K$702.45K-$688.68K-$2.55M-$1.57M-$2.13M-$683.56K$192.03K-$127.26K
    Financing cash flow$1.45M$1.30M-$1.32M-$4.04M$28.23M$22.37M$17.92M$10.25M$2.39M$2.51M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$442.16K-$722.50K-$812.46K-$240.75K-$704.20K-$189.48K-$317.95K$167.38K$289.78K-$704.07K-$105.88K-$263.50K
    Capital expenditures$18.07K$5.75K$164.80M$2.80K$1.48K$15.51K$164.39K$10.00K$1$4.62K$184.63K$120.18K
    Free cash flow-$460.22K-$728.25K-$165.61M-$243.55K-$705.67K-$204.98K-$482.34K$157.38K$289.78K-$708.69K-$290.51K-$383.68K
    Last 12 quarters

    Frequently Asked Questions About YCBD

    What is cbdMD's annual revenue?

    cbdMD reported revenue of $19.19M for the fiscal year ended Sep 30, 2025.

    How fast is cbdMD's revenue growing?

    Revenue was down 1.5% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -18.5%.

    Is cbdMD profitable?

    No. cbdMD reported net income of -$2.04M for the fiscal year ended Sep 30, 2025, with a net margin of -10.6%.

    How much free cash flow does YCBD generate?

    For the fiscal year ended Sep 30, 2025, operating cash flow of -$1.45M minus capital expenditures of $184.17K produced free cash flow of -$1.64M.

    How much debt does cbdMD have?

    The balance sheet dated Sep 30, 2025 reported short-term debt of $0 and cash and equivalents of $2.26M.